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Supporting Methods a. General aspects
All commercially available chemicals were purchased from Sigma-Aldrich, ABCR, TCI Europe, Acros Organics, Alfa Aesar, Fluka, Fluorochem, Merck or Ukrorgsyntez Ltd. and used without further purification. 1 H and 13 C spectra were recorded on a Bruker 500 MHz. Chemical shifts are reported in ppm (parts per million). Signals are quoted as s (singlet), d (doublet), t (triplet), bs (broad singlet) and m (multiplet). Electron-Spray Ionization Mass Spectra (ESI-MS) were recorded on a Bruker FTMS 4.7T bioAPEX II. High-resolution mass spectra (HRMS) were measured on a Bruker maXis 4G QTOF ESI mass spectrometer.
b. Cloning of constructs for periplasmic compartmentalization and surface display of CAII.
The CAII gene was amplified by polymerase chain reaction (PCR) from the plasmid "CAII cytoplasm " (Table S1 ) with the primers NheI-CAII_fwd and SacI-CAII_rev (Table S2 ) to introduce the restrictions sites NheI and SacI. The PCR product and the target vectors pET-30b_Sav peri1 and pET-30b_Lpp-OmpA-SavWT 2 (Table S1 ) were digested with the restriction enzymes NheI and SacI.
To digest the streptavidin (Sav) gene, AgeI was added to the vector digest. The vectors were dephosphorylated with antarctic phosphatase and gel-purified. The CAII-insert was ligated with T4 DNA ligase into the cut vectors resulting in the plasmids "CAII periplasm " (DNA sequence collected in Table S3 ) and "CAII surface display " (DNA sequence collected in Table S4 ). For the enzyme digest, dephosphorylation and ligation NEB protocols were followed.
c. Culture and expression conditions.
For this study, we used the strain Escherichia coli TOP10(DE3), previously reported. 1 The culture and expression conditions were adapted from previous publications. [1] [2] [3] In short, TOP10(DE3) E. coli cells containing an empty vector or plasmids for the compartmentalization of CAII in the cytoplasm, periplasm or on the cell surface (Table S1 ) were cultured independently as triplicate.
Overnight cultures in Luria-Bertani (LB) medium, supplemented with the appropriate antibiotic, S3 were used to inoculate the main culture (50 mL modified ZYM-5052 rich medium, see Table S5 ) in baffled Erlenmeyer flasks (volume: 250 mL) with an OD600 = 0.05. The flasks were incubated shaking at 220 rpm and 37 °C. At an OD600 between 0.5 and 1, the cultures were induced with Isopropyl β-D-1-thiogalactopyranoside (IPTG, 250 µM final concentration) and kept shaking at 220 rpm and 30 °C for another 4 h.
d. Synthesis
Cofactor 5 was synthesized according to a published procedure. 4 Profluorescent substrate 1 was synthesized according to a published procedure. 3 Scheme S1: a) DCC, HOBt, EDCI·HCl, DIPEA, DMF, 70 °C, 18 h, 63% b) [IrCp*Cl2]2, EtOH, 80 °C, 2 h, 34%.
Ligand 11. 4-hydroxypicolinic acid (50 mg, 0.36 mmol), HOBt (100 mg, 0.65 mmol), EDCI·HCl (140 mg, 0.73 mmol) and DIPEA (0.125 µL, 0.76 mmol) were added to a solution of 4-(aminomethyl)benzenesulfonamide (124 mg, 0.67 mmol) in DMF (3 mL). The solution was heated at 70 °C for 18 h. The solvents were removed in vacuo. The crude was purified using silica gel column chromatography (CH2Cl2/MeOH 95/5), followed by trituration in DCM to give ligand 11 (70 mg, 63%) as a white solid. Rf (CH2Cl2/MeOH 90/10): 0.24; 1 H NMR (500 MHz, DMSO-d6): 11.05 (bs, 1H), 9.37 (t, 3 JH-H = 6.5 Hz, NH, 1H), 8 .31 (bs, 1H), 7.76 (d, 3 JH-H = 8.0 Hz, 2H), 7.47 (d, 3 JH-H = 8.0 Hz, 2H), 7.42 (bs, 1H), 7.30 (s, 2H), 6 .92 (bs, 1H), 4.52 (d, 3 JH-H = 6.5 Hz, 2H); 13 Crystal plates of apo-CAII crystals (just containing a zinc in the active site) grew within five days.
To stabilize the crystals for soaking, a glutaraldehyde crosslinking was performed. 7 
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Diffraction data collection and processing. Protein-crystal diffraction data were collected (100 K) at the Swiss Light Source beam line PSI at a wavelength of 1.0 Å. Crystal indexing, integration and scaling 10, 11 were carried out with the program XDS 12 and Dials 13 in Xia2 10, 14 using the graphical interface CCP4i2 15 of the CCP4 suite 16 (see Table S6 for processing statistics).
Structure solution and refinement. The structure was solved by molecular replacement using the program PHASER MR 17 and the wild type CAII structure PDB: 3ZP9, devoid of the Ir-cofactor and water molecules. For structure refinement, REFMAC 18, 19 of the CCP4 Suite was used. For structure modelling, water picking and electron-density visualization the software COOT 20 was used. Figure S6 ). Compared to cofactor 7, cofactor 8 is shifted 2 Å closer to the a-helix of loop 4,5. To accommodate this, F130 moves slightly out of the CAII pocket to allow p-stacking with cofactor 8. Furthermore, E69 of CAII bound to the cofactor 7 moves 1.9 Å closer to the cofactor. We hypothesize that this may contribute to stabilize the bound cofactor 7. 
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